Frank Pétavy is a mathematician and biostatistician by training. He has worked 14 years in all phases of clinical development in the Pharmaceutical Industry before moving to EMA in 2012 where he was Head of Methodology until 2024. At EMA and during a secondment to the Dutch medicines Agency, Frank has been contributing to methodological aspects of Scientific Advice and Marketing Authorisation Applications. He has a wide experience in the development and review of methodological, clinical and quality guidelines at both European and international levels.